One of the main challenges in healthcare all over the word is to get reliable and fast diagnostic tools for infectious diseases to initiate fast treatment of the patients and to prevent the spreading of the infections.
The problem today is that most of the rapid detection systems are too complex to handle for other personnel than laboratory assistant or doctors.
Furthermore, the antibiotic resistance is also among the biggest threats to global health, food security, and development today, and is one of WHO highest priorities:
• Antibiotic resistance can affect anyone, of any age, in any country.
• Antibiotic resistance occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process.
• A growing number of infections are becoming harder to treat as the antibiotics used to treat them become less effective.
• Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality.
To prevent and control the spread of antibiotic resistance, WHO says that the health industry can:
“Invest in research and development of new antibiotics, vaccines, diagnostics and other tools”.
AptaSystem platform from Solsten Diagnostics A/S could be one of the diagnostic tools which can support the fast and reliable diagnosis and the control of the use of antibiotics.
The overall goal of the AptaCheck project is to optimize, test and commercialize our point-of-care (POC) platform AptaSystem® to detect infectious diseases. AptaSystem® is a patented platform technology providing with an easy, accurate and quick diagnosis of infectious diseases from any body fluids. A technology, which can be used by non-specialists in any environment. With AptaSystem® the user can get diagnostic results with laboratory quality in Point of Care/Point of Need settings for decision making.
AptaSystem is based on an electrical measurement on a lab-on-a-chip system (AptaChip®) which is inserted into the high precision reader device (AptaViewer®). Both the AptaChip and the AptaViewer are developed at Solsten Diagnostics A/S, and the AptaChips are produced with our in-house semi-automated, industrial pilot production line.
